Altered expression levels have been observed in patients suffering from Alzheimer's disease, and pre-treatment of primary hippocampal cultures with either Txn or Txnrd appear to ameliorate the effects of amyloid β[53]. This evidence concerns the gene TXN and early-onset autosomal dominant Alzheimer disease.